Impact of dipyridamole on adenosine dosing in pediatric and young adult patients after heart transplantation.

Pediatric Transplantation
Michael B SatzerEric S Silver

Abstract

Relative contraindications to adenosine use have included heart transplant and dipyridamole. We previously demonstrated the safety and efficacy of adenosine-induced atrioventricular (AV) block in healthy young heart transplant recipients while suspending dipyridamole therapy (dual antiplatelet agent). This prospective follow-up study evaluated the safety and efficacy of adenosine use in the same cohort of heart transplant recipients while on dipyridamole. Adenosine was incrementally dosed until AV block occurred (maximum 200 mcg/kg up to 12 mg). The primary outcome was clinically significant asystole (≥12 seconds). Secondary outcomes included maximal adenosine dose, AV block duration, dysrhythmias, and clinical symptoms. Outcomes were compared to the parent study. Thirty of 39 eligible patients (5-24 years) were tested. No patient (0%, CI 0%-8%) experienced clinically significant asystole. AV block occurred in 29/30 patients (97%, CI 86%-100%). The median dose causing AV block was 50mcg/kg (vs 100 mcg/kg off dipyridamole; P = .011). Seventeen patients (57%, CI 39%-72%) required less adenosine to achieve AV block on dipyridamole; six (20%) required more. AV block occurred at doses ≥25 mcg/kg in all patients. In pairwise comparis...Continue Reading

References

Apr 30, 1992·The New England Journal of Medicine·M Roelke, P M Yurchak
Oct 1, 1987·British Journal of Clinical Pharmacology·D GregovJ Lloyd
Mar 1, 1970·European Journal of Pharmacology·N KolassaW Rummel
Jan 1, 1983·Thrombosis Research. Supplement·T D Bjornsson, C Mahony
Sep 16, 1983·European Journal of Pharmacology·R E Klabunde
Feb 1, 1983·Journal of Clinical Pharmacology·C MahonyT D Bjornsson
Mar 1, 1982·Clinical Pharmacology and Therapeutics·C MahonyT D Bjornsson
Jan 1, 1994·Pharmaceutical Research·T L RussellJ B Dressman
Sep 1, 1993·Journal of the American College of Cardiology·N L McIntosh-YellinM M Scheinman
Aug 12, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·N J KerteszS W Denfield
Jan 5, 2005·Circulation·JoAnn LindenfeldGeraldine G Miller
Sep 29, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Martin J LaPageCharles E Canter
Jun 29, 2012·Clinical Cardiology·Jonathan Grinstein, Christopher P Cannon
Dec 21, 2014·Purinergic Signalling·Geoffrey Burnstock, Amir Pelleg
Aug 7, 2017·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Miae KimMichael M Givertz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

American Heart Journal
K J TuckerF Galli
International Journal of Cardiology
F ArrigoG Quattrocchi
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
Samia MassalhaIbrahim Marai
© 2021 Meta ULC. All rights reserved